Cargando…

Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials

INTRODUCTION: Randomized trials investigating neuromuscular blocking agents in adult acute respiratory distress syndrome (ARDS) have been inconclusive about effects on mortality, which is very high in this population. Uncertainty also exists about the associated risk of ICU-acquired weakness. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alhazzani, Waleed, Alshahrani, Mohamed, Jaeschke, Roman, Forel, Jean Marie, Papazian, Laurent, Sevransky, Jonathan, Meade, Maureen O
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672502/ https://www.ncbi.nlm.nih.gov/pubmed/23497608 http://dx.doi.org/10.1186/cc12557

Ejemplares similares

Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials
por: Tarazan, Nehal, et al.
Publicado: (2020)

Neuromuscular blocking agents for acute respiratory distress syndrome
por: Torbic, Heather, et al.
Publicado: (2019)

Is it appropriate for acute respiratory distress syndrome patients with neuromuscular blocking agents?
por: Tan, Zhimin, et al.
Publicado: (2023)

Effect of high-frequency oscillatory ventilation on esophageal and transpulmonary pressures in moderate-to-severe acute respiratory distress syndrome
por: Guervilly, Christophe, et al.
Publicado: (2016)

National incidence rate and related mortality for acute respiratory distress syndrome in France
por: Papazian, Laurent, et al.
Publicado: (2021)

Neuromuscular blocking agents for acute respiratory distress syndrome: an updated meta-analysis of randomized controlled trials
por: Zheng, Zhongjun, et al.
Publicado: (2020)

High levels of circulating leukocyte microparticles are associated with better outcome in acute respiratory distress syndrome
por: Guervilly, Christophe, et al.
Publicado: (2011)

Convalescent Plasma in COVID-19: To what Degree should Clinicians Rely on Currently Available Data?
por: Alhazzani, Waleed, et al.
Publicado: (2021)

Role of Neuromuscular Blocking Agents in Acute Respiratory Distress Syndrome: An Updated Meta-Analysis of Randomized Controlled Trials
por: Wei, Xue-biao, et al.
Publicado: (2020)

Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: a meta-analysis of randomized trials
por: Chang, Wei, et al.
Publicado: (2020)

Generation of a single pulmonary pressure-volume curve does not durably affect oxygenation in patients with acute respiratory distress syndrome
por: Roch, Antoine, et al.
Publicado: (2006)

Neuromuscular blocking agents for acute respiratory distress syndrome: how did we get conflicting results?
por: Torbic, Heather, et al.
Publicado: (2019)

Early neuromuscular blocking agents for adults with acute respiratory distress syndrome: a systematic review, meta-analysis and meta-regression
por: Shao, Shuai, et al.
Publicado: (2020)

Prophylactic Endotracheal Intubation in Patients with Upper Gastrointestinal Bleeding Undergoing Endoscopy: A Systematic Review and Meta-analysis
por: Alshamsi, Fayez, et al.
Publicado: (2017)

Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study
por: Courcelle, Romain, et al.
Publicado: (2020)

Formal guidelines: management of acute respiratory distress syndrome
por: Papazian, Laurent, et al.
Publicado: (2019)

The Implementation of Protocol-Based Utilization of Neuromuscular Blocking Agent Using Clinical Variables in Acute Respiratory Distress Syndrome Patients
por: Hadique, Sarah, et al.
Publicado: (2021)

Outcome of acute respiratory distress syndrome patients treated with extracorporeal membrane oxygenation and brought to a referral center
por: Roch, Antoine, et al.
Publicado: (2013)

The leukocyte-stiffening property of plasma in early acute respiratory distress syndrome (ARDS) revealed by a microfluidic single-cell study: the role of cytokines and protection with antibodies
por: Preira, Pascal, et al.
Publicado: (2016)

Chest CT scan and alveolar procollagen III to predict lung fibroproliferation in acute respiratory distress syndrome
por: Hamon, Annabelle, et al.
Publicado: (2019)

Pharmacological interventions in acute respiratory distress syndrome
por: Roch, Antoine, et al.
Publicado: (2013)

Early Hepatic Dysfunction Is Associated with a Worse Outcome in Patients Presenting with Acute Respiratory Distress Syndrome: A Post-Hoc Analysis of the ACURASYS and PROSEVA Studies
por: Dizier, Stéphanie, et al.
Publicado: (2015)

Neuromuscular blocking agents in patients with acute respiratory distress syndrome: a summary of the current evidence from three randomized controlled trials
por: Pereira, VGM
Publicado: (2013)

Neuromuscular blocking agents in patients with acute respiratory distress syndrome: a summary of the current evidence from three randomized controlled trials
por: Neto, Ary Serpa, et al.
Publicado: (2012)

Neuromuscular blocking agents in the intensive care unit
por: Rodríguez-Blanco, Jonathan, et al.
Publicado: (2022)

Prolonged neuromuscular blockade by non-depolarizing neuromuscular blocking agents
por: Higashi, Michiko, et al.
Publicado: (2019)

The role of eosinophils in sepsis and acute respiratory distress syndrome: a scoping review
por: Al Duhailib, Zainab, et al.
Publicado: (2021)

Transforming Growth Factor-β1 in predicting early lung fibroproliferation in patients with acute respiratory distress syndrome
por: Forel, Jean-Marie, et al.
Publicado: (2018)

Flexible organic frameworks sequester neuromuscular blocking agents in vitro and reverse neuromuscular block in vivo
por: Wu, Yan, et al.
Publicado: (2022)

Neuromuscular blockers in the acute respiratory distress syndrome: A meta-analysis
por: Hua, Yusi, et al.
Publicado: (2020)

Tracheal Intubation Without the Use of Neuromuscular Blocking Agents
por: Prakash, Smita
Publicado: (2012)

High Respiratory Drive and Excessive Respiratory Efforts Predict Relapse of Respiratory Failure in Critically Ill Patients with COVID-19
por: Esnault, Pierre, et al.
Publicado: (2020)

Contemporary Ventilation Strategies And Adjunctive Therapies For Acute Respiratory Distress Syndrome (Ards)
por: Duan, EH, et al.
Publicado: (2015)

Effect of Prone Positioning on the Respiratory Support of Nonintubated Patients With COVID-19 and Acute Hypoxemic Respiratory Failure: A Retrospective Matching Cohort Study
por: Prud’homme, Eloi, et al.
Publicado: (2021)

Typologies of Decision-Makers in the ICU: A Qualitative Study of Patients With Acute Respiratory Distress Syndrome and Sepsis and Their Surrogates
por: Lava, Michael S., et al.
Publicado: (2019)

Urgent intubation without neuromuscular blocking agents and the risk of tracheostomy
por: Fujinaga, Jun, et al.
Publicado: (2019)

The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents
por: Honore, Patrick M., et al.
Publicado: (2020)

Promoting Evidence-Based Practice in Acute Respiratory Distress Syndrome: A Systematic Review
por: Giovanni, Shewit P., et al.
Publicado: (2021)

Small bowel feeding and risk of pneumonia in adult critically ill patients: a systematic review and meta-analysis of randomized trials
por: Alhazzani, Waleed, et al.
Publicado: (2013)

Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And Fluoroquinolones
por: Elst, Jessy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qle09eps7v1ih5hd0p50nh8btp